Bone Biologics (BBLG) News Today $1.01 -0.04 (-3.81%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Headlines Stock AnalysisChartFinancialsSEC Filings All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Bone Biologics Appoints Phillip T. Meikle to its Board of DirectorsOctober 21, 2024 | finance.yahoo.comBone Biologics (NASDAQ:BBLG) Stock, Short Interest ReportSeptember 17, 2024 | benzinga.comBone Biologics Corporation to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 4, 2024 | finance.yahoo.comBone Biologics Announces Exercise of Warrants for $2.1 Million Gross ProceedsAugust 2, 2024 | finance.yahoo.comBone Biologics Announces Pricing Of $2 Mln Public OfferingMarch 4, 2024 | markets.businessinsider.comBone Biologics rises 5% on $2M equity offeringMarch 4, 2024 | msn.comBone Biologics stock jumps after reporting progress with NB1 clinical programMarch 1, 2024 | msn.comBBLG Releases Annual Report Amid Continued Pursuit of Breakthrough TreatmentFebruary 22, 2024 | finance.yahoo.comBone Biologics Appoints Healthcare Finance Veteran Robert E. Gagnon to Board of DirectorsJanuary 11, 2024 | finance.yahoo.comWhat's Going On With Bone Biologics Corp Stock?December 28, 2023 | msn.comBBLG Announces Split as Pursuit of Breakthrough Treatment ContinuesDecember 20, 2023 | finance.yahoo.comBone Biologics to conduct 1-for-8 reverse stock splitDecember 18, 2023 | msn.comBone Biologics Authorised For 1-for-8 Reverse Stock SplitDecember 18, 2023 | markets.businessinsider.comBone Biologics Announces 1-for-8 Reverse Stock SplitDecember 18, 2023 | finance.yahoo.comWhy Bone Biologics Stock (BBLG) Is Falling SharplyNovember 20, 2023 | msn.comBone Biologics Announces Closing of Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNovember 20, 2023 | finance.yahoo.comWhy Bone Biologics Stock (BBLG) Is Getting Obliterated FridayNovember 17, 2023 | msn.comBone Biologics Announces Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNovember 16, 2023 | finance.yahoo.comBBLG Offers Good Entry OpportunityNovember 15, 2023 | finance.yahoo.comWhat Are Biologics?November 14, 2023 | msn.comBone Biologics Corp BBLGNovember 14, 2023 | morningstar.comBone Biologics Provides Scientific Update on NB1 Bone Graft DeviceSeptember 26, 2023 | finance.yahoo.comRobin Roberts' sister reflects on sibling's upcoming wedding after lifesaving bone marrow donationSeptember 24, 2023 | abcnews.go.comBone brothSeptember 22, 2023 | bbc.co.ukInsider Buying: CFO Deina Walsh Acquires 8,000 Shares of Bone Biologics Corp (BBLG)September 15, 2023 | finance.yahoo.comCEO Jeff Frelick Buys 9,500 Shares of Bone Biologics Corp (BBLG)September 13, 2023 | finance.yahoo.comMan killed roommate, and lived with body in closet for monthsAugust 23, 2023 | nypost.comTB death in Michigan linked to contaminated bone graft materialAugust 17, 2023 | detroitnews.comBBLG Advances Crucial Technology and Solidifies FundingAugust 15, 2023 | finance.yahoo.comSecond deadly TB outbreak linked to tainted bone graftsAugust 4, 2023 | msn.comDeadly tuberculosis outbreaks in US linked to tainted bone graftsJuly 31, 2023 | msn.comBone Biologics (BBLG) Price Target Increased by 738.89% to 38.51July 6, 2023 | msn.comBioMedNewsBreaks - Bone Biologics Corporation (NASDAQ: BBLG) Announces $5M Underwritten Public OfferingJune 22, 2023 | marketwatch.comBone Biologics stock plummets more than 50% after stock offering prices at deep discountJune 16, 2023 | msn.comBone Biologics slumps 50%, prices $5M offeringJune 15, 2023 | msn.comBone Biologics Nosedives on $5M Stock OfferingJune 15, 2023 | msn.comBone Biologics Prices $5.0 Million Underwritten Public OfferingJune 15, 2023 | finance.yahoo.comBBLG - Bone Biologics CorporationJune 8, 2023 | finance.yahoo.comBBLG: BBLG Advances Crucial Technology and Solidifies FundingJune 8, 2023 | finance.yahoo.comBone Biologics Effects 1-for-30 Reverse Stock SplitJune 6, 2023 | finance.yahoo.comBBLG: BBLG Has Solid Cash and Is Advancing TestingMay 16, 2023 | finance.yahoo.comS-1: Bone Biologics CorpMay 2, 2023 | marketwatch.comBBLG: Bone Biologics Announces the Approval of A Vital TrialApril 11, 2023 | finance.yahoo.comBone Biologics Receives Human Research Ethics Committee Approval to Begin Pilot Clinical Trial with NB1 in Spinal Fusion Patients in AustraliaApril 11, 2023 | finance.yahoo.comSynthetic Dental Bone Graft Substitute Market Future Plans and Forecast 2023-2028April 6, 2023 | marketwatch.comBone Growth Therapy Devices Market Top Players and Forecast till 2031April 5, 2023 | marketwatch.comBone Growth Stimulator Market | Growth Prospects by 2023-2028March 29, 2023 | marketwatch.comBone Growth Stimulator Market Growth, Business Overview and Forecast to 2031March 29, 2023 | marketwatch.comLatest "Spine Biologics Market" Highlights 2023-2031, With New ReportMarch 27, 2023 | marketwatch.comBBLG: BBLG Provides Investment Opportunity Before TrialsMarch 17, 2023 | finance.yahoo.com Get Bone Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for BBLG and its competitors with MarketBeat's FREE daily newsletter. Email Address Missed Nvidia? Buy Elon Musk’s “Silent Partner” (Ad)In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my favorite stocks. Today, it’s probably the most popular stock in the world. I believe this Elon Musk “silent partner” could be the next big AI winner. So please click here to see the details because a lot of people could get rich. BBLG Media Mentions By Week BBLG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BBLG News Sentiment▼0.000.59▲Average Medical News Sentiment BBLG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BBLG Articles This Week▼00▲BBLG Articles Average Week Get Bone Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for BBLG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies QTI News PXDT News PETV News ICU News STRR News PAVM News NURO News TTOO News SIGY News CUTR News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTC:BBLG) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bone Biologics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bone Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.